Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer. 

Biotechnology

Cytocom

Cytocom's headquarters in Fort Collins, CO, United States

Peter Aronstam

Taunia Markvicka

Allie Lopez

Kelly Wilson

Fengping Shan

Lea Verny

Randy Saluck

Steve Barbarick

The Leadership Team at Cytocom comprises senior executives who drive the strategic direction of the company in developing innovative immune therapies. They collaborate on key areas such as corporate development, regulatory affairs, research and development, and financial management to ensure the successful advancement of clinical programs in diseases like Crohn’s and pancreatic cancer. This team is pivotal in aligning organizational goals, fostering innovation, and securing resources necessary for the company's growth and advancement in the biopharmaceutical industry.

Leadership Team

The Clinical Operations and Development team at Cytocom is responsible for overseeing the planning, execution, and management of clinical trials for the company’s novel immune therapies. This team collaborates closely with regulatory affairs and medical experts to ensure compliance with guidelines while driving projects forward, from trial design to data analysis. Their efforts are crucial in advancing Cytocom’s innovative treatments for Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer toward successful market entry.

Cytocom

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Development

Offices

Cytocom

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations and Development

Offices

Related companies